Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA), Aurobindo Pharma Limited (BSE:524804), Cadila Healthcare Limited (BSE:532321) and Torrent Pharmaceuticals Limited (BSE:500420) are looking to acquire manufacturing assets in the US.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,185 INR | -0.27% |
|
+1.66% | +71.91% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,973 INR | +0.75% | +1.27% | 12.04B | ||
1,579 INR | -0.44% | -0.38% | 45.35B | ||
1,371 INR | -0.28% | +2.90% | 9.61B | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.91% | 14.27B | |
+25.40% | 45.35B | |
+38.38% | 24.34B | |
+26.72% | 16.51B | |
+21.19% | 14.6B | |
-0.05% | 6.79B | |
-11.63% | 6.57B | |
+15.08% | 5.76B | |
-8.87% | 5.73B | |
+35.91% | 5.01B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Sun Pharma, Cadila, Aurobindo and Torrent Eyes Stake In Manufacturing Assets In The US